Results 211 to 220 of about 18,846,310 (227)

Mitomycin C.

Cancer chemotherapy and biological response modifiers, 1992
N W, Gibson, D, Siegel, D, Ross
openaire   +1 more source

Uses and complications of mitomycin C in ophthalmology

Expert Opinion on Drug Safety, 2007
Ioannis M Aslanides
exaly  

A phase III randomized trial of 5-fluorouracil, doxorubicin,and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer

Annals of Oncology, 2002
Dae-Seog Heo, H M Chang, K U Lee
exaly  

Mitomycin C

2008
openaire   +1 more source

Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes

Canadian Journal of Ophthalmology, 2006
Sanjay K Murthy, William G Hodge, Karim F Damji   +2 more
exaly  

KW-2149 (7-N-[2-[Y-L-glutamylamino]ethyldithioethyl]mitomycin C) a new mitomycin c analogue activated by serum

Biochemical Pharmacology, 1997
Hans Hendriks, John A Hartley, Lloyd R Kelland   +2 more
exaly  

Mitomycin C

2005
openaire   +1 more source

Mitomycin C.

Cancer chemotherapy and biological response modifiers, 1995
N W, Gibson, R M, Phillips, D, Ross
openaire   +1 more source

Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and Toxicity

Journal of Urology, 2003
exaly  

The mitomycin bioreductive antitumor agents: Cross-linking and alkylation of DNA as the molecular basis of their activity

Pharmacology & Therapeutics, 1997
Maria Tomasz, M Tomasz
exaly